• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶受体。一种细胞表面的、受调控的趋化因子。

The urokinase receptor. A cell surface, regulated chemokine.

作者信息

Blasi F

机构信息

Dipartimento di Ricerca Biologica e Tecnologica, H.S. Raffaele, Milano, Italy.

出版信息

APMIS. 1999 Jan;107(1):96-101. doi: 10.1111/j.1699-0463.1999.tb01531.x.

DOI:10.1111/j.1699-0463.1999.tb01531.x
PMID:10190285
Abstract

Mice deficient for the urokinase plasminogen activator (uPA) gene are deficient in the recruitment of T cells and macrophages and succumb to bacterial infections. High levels of uPA or of its receptor (uPAR, CD87) are produced in human cancers and are strong prognostic indicators of relapse. Thus uPA and uPAR have a profound influence on cell migration. This set of molecules is known to regulate surface proteolysis, cell adhesion and chemotaxis. We have investigated the mechanism involved in uPAR-dependent chemotaxis. Chemotaxis is induced through an uPA-dependent conformational change in uPAR which uncovers a very potent chemotactic epitope acting through a pertussis-toxin sensitive step and activating intracellular tyrosine kinases. The epitope is located in the linker region between domain D1 and D2 of uPAR. Binding of uPA transforms uPAR from a receptor for uPA into a pleiotropic ligand ("activated uPAR") for other still unidentified surface molecules. Through these "adaptors", uPAR causes cytoskeletal changes, activation of kinases and directional cell migration. The conformational change can be substituted by cleavage between domain D1 and D2, in an area that can be cleaved by uPA itself at high efficiency.

摘要

尿激酶型纤溶酶原激活剂(uPA)基因缺陷的小鼠在募集T细胞和巨噬细胞方面存在缺陷,并易死于细菌感染。在人类癌症中会产生高水平的uPA或其受体(uPAR,CD87),并且是复发的强有力预后指标。因此,uPA和uPAR对细胞迁移有深远影响。已知这组分子可调节表面蛋白水解、细胞粘附和趋化作用。我们研究了uPAR依赖性趋化作用所涉及的机制。趋化作用是通过uPAR中依赖于uPA的构象变化诱导的,该变化揭示了一个非常有效的趋化表位,其作用通过百日咳毒素敏感步骤并激活细胞内酪氨酸激酶。该表位位于uPAR的D1和D2结构域之间的连接区域。uPA的结合将uPAR从uPA的受体转变为其他仍未确定的表面分子的多效性配体(“活化的uPAR”)。通过这些“衔接子”,uPAR引起细胞骨架变化、激酶激活和细胞定向迁移。这种构象变化可以通过在D1和D2结构域之间的区域进行切割来替代,该区域可被uPA自身高效切割。

相似文献

1
The urokinase receptor. A cell surface, regulated chemokine.尿激酶受体。一种细胞表面的、受调控的趋化因子。
APMIS. 1999 Jan;107(1):96-101. doi: 10.1111/j.1699-0463.1999.tb01531.x.
2
Structure and function of the urokinase receptor.尿激酶受体的结构与功能。
Thromb Haemost. 1999 Sep;82 Suppl 1:19-22.
3
A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.人尿激酶受体的一个尿激酶敏感区域负责其趋化活性。
EMBO J. 1997 Dec 15;16(24):7279-86. doi: 10.1093/emboj/16.24.7279.
4
Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2.尿激酶通过尿激酶受体表位诱导嗜碱性粒细胞趋化,该表位是类甲酰肽受体1和类甲酰肽受体2的内源性配体。
J Immunol. 2004 Nov 1;173(9):5739-48. doi: 10.4049/jimmunol.173.9.5739.
5
The cleavage of the urokinase receptor regulates its multiple functions.尿激酶受体的裂解调节其多种功能。
J Biol Chem. 2002 Dec 6;277(49):46932-9. doi: 10.1074/jbc.M207494200. Epub 2002 Sep 23.
6
Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.尿激酶型纤溶酶原激活剂(uPA)kringle结构域与整合素αvβ3的直接相互作用可诱导信号转导并增强纤溶酶原激活。
Thromb Haemost. 2006 Mar;95(3):524-34. doi: 10.1160/TH05-06-0457.
7
Interplay of human tissue kallikrein 4 (hK4) with the plasminogen activation system: hK4 regulates the structure and functions of the urokinase-type plasminogen activator receptor (uPAR).人组织激肽释放酶4(hK4)与纤溶酶原激活系统的相互作用:hK4调节尿激酶型纤溶酶原激活剂受体(uPAR)的结构和功能。
Biol Chem. 2006 Feb;387(2):217-22. doi: 10.1515/BC.2006.029.
8
The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis.尿激酶对平滑肌细胞的趋化作用取决于其kringle结构域。相互作用的表征及其对趋化作用的贡献。
J Biol Chem. 2000 Jun 2;275(22):16450-8. doi: 10.1074/jbc.M909080199.
9
The urokinase receptor is required for human monocyte chemotaxis in vitro.体外人类单核细胞趋化性需要尿激酶受体。
J Clin Invest. 1994 Apr;93(4):1380-7. doi: 10.1172/JCI117114.
10
Urokinase receptor variants in tissue and body fluids.组织和体液中的尿激酶受体变体。
Adv Clin Chem. 2007;44:65-102.

引用本文的文献

1
Transcriptomic Profiling of the Immune Response in Orthotopic Pancreatic Tumours Exposed to Combined Boiling Histotripsy and Oncolytic Reovirus Treatment.原位胰腺癌在接受联合沸腾组织粉碎术和溶瘤呼肠孤病毒治疗后免疫反应的转录组分析
Pharmaceutics. 2025 Jul 22;17(8):949. doi: 10.3390/pharmaceutics17080949.
2
The Urokinase Receptor (uPAR) as a "Trojan Horse" in Targeted Cancer Therapy: Challenges and Opportunities.尿激酶受体(uPAR)作为靶向癌症治疗中的“特洛伊木马”:挑战与机遇
Cancers (Basel). 2021 Oct 27;13(21):5376. doi: 10.3390/cancers13215376.
3
SCUBE1: a promising biomarker in renal cell cancer.
信号肽CUB和表皮生长因子样结构域蛋白1:肾细胞癌中有前景的生物标志物
Int Braz J Urol. 2017 Jul-Aug;43(4):638-643. doi: 10.1590/S1677-5538.IBJU.2016.0316.
4
Suppression of uPAR retards radiation-induced invasion and migration mediated by integrin β1/FAK signaling in medulloblastoma.uPAR 的抑制作用可减缓整合素 β1/FAK 信号介导的髓母细胞瘤辐射诱导的侵袭和迁移。
PLoS One. 2010 Sep 24;5(9):e13006. doi: 10.1371/journal.pone.0013006.
5
PLAUR polymorphisms and lung function in UK smokers.PLAUR 多态性与英国吸烟者的肺功能。
BMC Med Genet. 2009 Oct 31;10:112. doi: 10.1186/1471-2350-10-112.
6
Urokinase receptor mediates lung fibroblast attachment and migration toward provisional matrix proteins through interaction with multiple integrins.尿激酶受体通过与多种整合素相互作用,介导肺成纤维细胞对临时基质蛋白的附着和迁移。
Am J Physiol Lung Cell Mol Physiol. 2009 Jul;297(1):L97-108. doi: 10.1152/ajplung.90283.2008. Epub 2009 May 1.
7
Mechanisms of kringle fragment of urokinase-induced vascular smooth muscle cell migration.尿激酶kringle片段诱导血管平滑肌细胞迁移的机制
J Surg Res. 2007 Jul;141(1):83-90. doi: 10.1016/j.jss.2007.03.069.
8
Down-regulation of uPAR and uPA activates caspase-mediated apoptosis and inhibits the PI3K/AKT pathway.尿激酶型纤溶酶原激活物受体(uPAR)和尿激酶型纤溶酶原激活物(uPA)的下调激活半胱天冬酶介导的细胞凋亡并抑制磷脂酰肌醇-3激酶/蛋白激酶B(PI3K/AKT)信号通路。
Int J Oncol. 2007 Jul;31(1):19-27.
9
Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth.使用小干扰发夹RNA(siRNA)下调尿激酶型纤溶酶原激活物(uPA)、尿激酶型纤溶酶原激活物受体(uPAR)和基质金属蛋白酶-9(MMP-9)可抑制胶质瘤细胞的侵袭、血管生成和肿瘤生长。
Neuron Glia Biol. 2004 May;1(2):165-76. doi: 10.1017/s1740925x04000237.
10
Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation.人类核糖核酸酶A超家族成员,嗜酸性粒细胞衍生神经毒素和胰腺核糖核酸酶,可诱导树突状细胞成熟和激活。
J Immunol. 2004 Nov 15;173(10):6134-42. doi: 10.4049/jimmunol.173.10.6134.